Gut-Brain connection in IBS: scientists hunt for clues to anxiety and depression
NCT ID NCT07646834
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates how the gut and brain communicate in people with Irritable Bowel Syndrome (IBS) who also experience anxiety or depression. Researchers will compare 100 IBS patients with anxiety or depression to 100 healthy volunteers using brain scans, stool samples, and blood tests. No treatments are given; the goal is to find biological markers that could improve diagnosis and future care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could identify biological markers that help diagnose or guide future treatments for IBS with anxiety and depression.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead directly to new therapies, and results may not apply to all IBS patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults (18-60 years) with irritable bowel syndrome (IBS) meeting Rome IV criteria and healthy right-handed volunteers, all with at least 6 years of education.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Right-handed, aged 18-60 years, with more than 6 years of education; 2. Meeting the Rome IV diagnostic criteria for IBS: Symptoms have been present for at least 6 months, and for the last 3 months, the following criteria are met: recurrent abdominal pain or discomfort, with symptoms occurring on at least 3 days per month in the last 3 months, associated with two or more of the following: 1) Improvement with defecation; 2) Onset associated with a change in frequency of stool; 3) Onset associated with a change in form (appearance) of stool; 3. The following symptoms support the diagnosis of IBS: 1) Abnormal stool frequency: \<3 bowel movements per week or \>3 bowel movements per day; 2) Abnormal stool form: lumpy/hard stool or mushy/watery stool; 3) Straining during defecation; 4) Urgency or a feeling of incomplete evacuation; 5) Passage of mucus; 6) Bloating. Exclusion Criteria: 1. History of anti-anxiety/depressant medication use (e.g., SSRI/SNRI, Chinese patent medicines) within the past 1 month; 2. History of antibiotic or probiotic use within the past 1 month; 3. Other gastrointestinal diseases such as IBD, intestinal obstruction, or history of gastrointestinal surgery; 4. Current or past history of psychiatric or neurological disorders, such as psychosis, brain tumors, or impaired consciousness; 5. Concurrent severe hepatic or renal insufficiency, cardiovascular or cerebrovascular diseases, or malignant tumors; 7.0T MRI Contraindications: Presence of ferromagnetic implants (e.g., cardiac pacemakers, defibrillators, neurostimulators, aneurysm clips, cochlear implants, or any metallic foreign bodies); Non-ferromagnetic implants (e.g., titanium alloy, orthopedic implants), various types of intrauterine devices, various types of non-removable dentures (including dental implants); Presence of metallic foreign bodies (e.g., metal fragments, shrapnel, or filings in the eyes or body), such as in individuals engaged in welding work or with a history of metal item trauma; Tattoos or permanent makeup (e.g., eyebrows, lips) applied within the past month; Claustrophobia; Fever. HC Group Inclusion Criteria (all must be met): 1. Right-handed, aged 18-60 years, with more than 6 years of education; 2. All physiological indicators are within normal ranges, with no signs of disease; 3. No family history of psychiatric or neurological disorders.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Tangdu Hospital, Air Force Medical University
RECRUITINGXi'an, Shaanxi, 710038, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Can a phone app that blocks distracting apps ease depression?
- Can video games calm anxious teens?
- Can teachers and a phone app ease teen depression?
- Can imagining exercise boost brain power after spinal cord injury?
- Can a group program teach teens to cope before therapy starts?